Clinical trial

Tamoxifen-MRI Study

NCT00295100

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2000-09-01

PhasePHASE2

Study timeline

Study start (unknown)2000-09-01Date precision: month

Registry last updated2007-06-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

TamoxifenDRUG · verified · RxNorm: tamoxifen

Sponsors & collaborators

University of Pennsylvanialead sponsor

National Cancer Institute (NCI)collaborator

AstraZenecacollaborator

Mapped research locations

PhiladelphiaPennsylvania, United States2 BostonMassachusetts, United States1 Los AngelesCalifornia, United States1 DetroitMichigan, United States1 MilanItaly1 RochesterMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00295100 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.